Supplementary Table S3 from Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer
Authors:
- Mohamed A. GoudaMGMohamed A. Gouda
- Amrit GonuguntaAGAmrit Gonugunta
- Ecaterina E. DumbravaEDEcaterina E. Dumbrava
- Timothy A. YapTYTimothy A. Yap
- Jordi RodonJRJordi Rodon
- Sarina A. Piha-PaulSPSarina A. Piha-Paul
- Paula R. PohlmannPPPaula R. Pohlmann
- Senthil DamodaranSDSenthil Damodaran
- Rashmi MurthyRMRashmi Murthy
- Vicente ValeroVVVicente Valero
- Jason A. MouabbiJMJason A. Mouabbi
- Debasish TripathyDTDebasish Tripathy
Open Access
- 1 April 2025
- other
- Published by American Association for Cancer Research (AACR)